Dimensional Fund Advisors LP
- SEC CIK
- 0000354204
- Latest filing
- Aug 11, 2026
ACRV holding history
Acrivon Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACRV overviewAll 13F holders of ACRVFull Q2 2026 holdings
- Shares (Q2 2026)
- 29,332
- Value
- $52.2K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 29,332 | $52.2K | <0.1% | +10,968+59.7% | Added | Holders |
| Q1 2026 | 18,364 | $25.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 18,364 | $44.3K | <0.1% | −1,215−6.2% | Reduced | Holders |
| Q3 2025 | 19,579 | $35.5K | <0.1% | −2,625−11.8% | Reduced | Holders |
| Q2 2025 | 22,204 | $26.4K | <0.1% | −21,950−49.7% | Reduced | Holders |
| Q1 2025 | 44,154 | $90.0K | <0.1% | +7,091+19.1% | Added | Holders |
| Q4 2024 | 37,063 | $223.1K | <0.1% | +6,239+20.2% | Added | Holders |
| Q3 2024 | 30,824 | $215.8K | <0.1% | +20,758+206.2% | Added | Holders |
| Q2 2024 | 10,066 | $58.4K | <0.1% | +10,066 | New | Holders |